Skip to content
Doctor Evidence
  • Products
    • DOC Search
    • DOC Library
    • DOC Data
    • DOC Label
    • Global Health
    • DOC TRACK
    • DOC Congress
  • Services
    • Reviews
    • Analyses
  • Programs
    • COE
    • GROWTH
    • Training
    • AI
    • SERVE
    • IEM
    • SAW
  • Publications
    • Manuscripts
    • Posters
  • About
    • News
    • Leadership
    • Contact Us
  • Login
Doctor Evidence
Manuscript

Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.

Posted September 11, 2011September 19, 2018 Doctor Evidence

AUTHORS: Berenson, K.L., Kymes, S., Hollander, D.A., Fiscella, R., Burk, C. and Patel, V.D.

Publication: The American journal of managed care 17.9 (2011): e365-74.

YEAR: 2011

Read article
Cost-offset analysis-bimatoprost
GlaucomaOphthalmology

Post navigation

⟵Demonstration of an Online Tool to Assist Care Formulary Evidence-based Decision-making: Meta-analysis of Topical Prostaglandin Analog Efficacy.
Methods for Comparative Effectiveness Research.⟶

Search our site:

Topics of Interest

Arthritis Arthroplasty Artificial Intelligence Cardiology Cardiovascular COPD Coronary Syndrome Data Mining Diabetes Mellitus Endocrinology Glaucoma guideli Guideline Development Hypertension Immunotherapy Infectious Disease Influenza Lung Cancer Machine Learning Meta-Analysis Nephrology Network Meta-Analysis NSCLC Oncology Ontology Ophthalmology Osteoarthritis Pleural Effusions Respiratory Respiratory Syncytial Virus Rheumatoid Arthritis Rheumatology Stroke Syncope Systematic Review Type 2 Diabetes Mellitus Vaccination

Connect with us

Search our site: